SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of St. Jude Medical, Inc. & Encourages Inve...
May 02 2016 - 12:39PM
Business Wire
The securities litigation law firm of Brower Piven, A
Professional Corporation, has commenced an investigation into
possible breaches of fiduciary duty and other violations of state
law by the Board of Directors of St. Jude Medical, Inc. (St. Jude
or the “Company”) (NYSE: STJ) relating to the proposed buyout of
the Company by Abbott Laboratories, in a transaction valued at
approximately $25 billion.
Under the terms of the agreement, St. Jude shareholders are
anticipated to receive $46.75 in cash and 0.8708 shares of Abbott
common stock for each share of St. Jude common stock held. The
firm’s investigation seeks to determine, among other things,
whether the Company’s Board of Directors failed to satisfy their
duties to shareholders, including whether the Board adequately
pursued alternatives to the acquisition and whether the Board
obtained the best price possible for the Company’s shares of common
stock.
If you currently own common stock of St. Jude and believe that
the proposed buyout price is too low, or you would like to learn
more about the investigation being conducted by Brower Piven,
please visit our website at
http://www.browerpiven.com/currentinvestigations.html. You may also
request more information by contacting Brower Piven either by email
at hoffman@browerpiven.com or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in
litigating securities and other class action cases and have been
advocating for the rights of shareholders since the 1980s.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160502005928/en/
Brower Piven, A Professional CorporationCharles J. Piven,
410-415-66161925 Old Valley RoadStevenson, Maryland
21153hoffman@browerpiven.com
SJM (NYSE:STJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Apr 2023 to Apr 2024